First-of-its kind guideline on lipid monitoring in endocrine diseasesNovember 6, 2020Lipid DisordersDiabetes
Novel drug slows progression of diabetic kidney diseaseOctober 29, 2020DiabetesHeart FailureAcute Coronary SyndromesStrokeMixed Topics
Entresto halves renal events in preserved EF heart failure patientsOctober 15, 2020Heart FailureDiabetes
T2D treatments create tension between glycemic and cardiovascular goalsOctober 12, 2020DiabetesPreventive Care
EMPEROR-Reduced: Empagliflozin’s HFrEF benefit holds steady on top of sacubitril/valsartanOctober 6, 2020Heart FailureDiabetes
Dapagliflozin’s CKD performance sends heart failure messagesOctober 5, 2020Heart FailureDiabetesInterventional Cardiology & Surgery
